Earnings
Kyndryl Holds Its Full-Year Outlook As Quarterly Net Income Slips To $59 Million
Workforce charges doubled to $38 million and free cash flow turned negative, while adjusted earnings rose to $0.42 a share.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Earnings
Workforce charges doubled to $38 million and free cash flow turned negative, while adjusted earnings rose to $0.42 a share.
SEC Filings
The biotech's cash fell to $498.5 million as an undrawn $50.0 million tranche folded into a lender-approval tranche now up to $250.0 million.
SEC Filings
The coal royalty owner will pay $32 million to unitholders on November 24, with $14.3 million of debt left to retire in December.
Earnings
The chip and components maker swung to $0.37 a share from a loss and guided fourth-quarter revenue to $990 million, plus or minus $15 million.
Deals
The proposed Webster Equity Partners deal pushed up the value of Alcon's early-repayment option and drove a $1.08-per-share quarterly loss.
SEC Filings
The RNAi drugmaker's new $400 million term loan matures in November 2031 and carries no required sweeps of partnership or product revenue.
Deals
Acquisitions lifted sales and adjusted EBITDA in the third quarter, while falling aggregates prices and higher costs cut per-share earnings.
Earnings
The Omnipod maker also raised its adjusted operating margin outlook after third-quarter net income reached $141.1 million.
SEC Filings
The company also launched a three-course developer training path, with benchmark gains on routing and assembly-line problems.
Earnings
Gains on restaurant sales and higher franchised margins carried quarterly profit, while the CEO pointed to a U.S. pickup after its value push.
SEC Filings
Kelly Dilts of Nordstrom and ex-Kroger finance chief Mike Schlotman become independent directors as the food maker pursues its transformation plan.
SEC Filings
The financing half of the July award vested once the cash was raised, while the clinical half is not yet counted as granted.